Artificial intelligence (AI) is transforming healthcare across multiple fields, and prostate cancer (PCa)  is no exception. A ...

Molecular subtyping is a way of classifying breast cancer tumors into one of four genetically-distinct categories, or subtypes: Luminal A, Luminal B, Basal (a subset of triple negative), and HER2 ...

Molecular subtyping is a way of classifying breast cancer tumors into one of four genetically-distinct categories, or subtypes: Luminal A, Luminal B, Basal (a subset of triple negative), and HER2 ...

Standard pathology tests outperform molecular subtyping in bladder cancer Date: December 13, 2019 Source: Medical College of Georgia at Augusta University Summary: While trying to develop a ...

Subtyping tests should be performed in the hospital clinical lab if possible. Otherwise they should be sent to a commercial clinical lab, or if that's not available, a public health lab.

NEW HAVEN, Conn., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the launch of a new version of its Bloodhound MPN ...

Speedier Subtyping Improves Outcomes “Given the high burden of respiratory infections in the winter, expedited subtyping of influenza is essential to differentiating seasonal respiratory viruses ...

The CDC is calling on doctors and hospitals to perform subtyping on all hospitalized patients who test positive for influenza A, ideally within 24 hours of admission. “It’s the subtyping that ...

Aleix Prat´s research has not only associated different molecular subtypes of breast cancer with disease prognosis and prediction of response to hormone therapy, but also now evidences intrinsic ...

In this video, Joshua Brody, MD, director of the lymphoma immunotherapy program at the Icahn School of Medicine at Mount Sinai, discusses the latest advancements in DLBCL subtying and classification.